Global Health Ltd.
NSE: MEDANTA · Hospital
Snapshot
Unlock Global Health Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Global Health Limited is a multi-specialty tertiary care provider operating under the Medanta brand. The company delivers advanced medical treatments across various disciplines including cardiology, neurosciences, oncology, and organ transplantation through its network of hospitals in India.
Business Model
The company generates revenue by providing comprehensive healthcare services, including inpatient and outpatient care, diagnostic services, and complex surgical procedures. It operates a hub-and-spoke model with large-scale hospitals located in key Indian cities.
Growth Outlook
Growth is driven by the expansion of bed capacity across its existing hospital network and the increasing demand for high-end tertiary and quaternary care services in India. The company continues to focus on clinical excellence and the integration of advanced medical technologies.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including doctors and nursing staff, which may affect service quality and operational costs.
- Operational Concentration. The company's performance is heavily dependent on the operational success of its specific hospital locations in Gurugram, Indore, Ranchi, and Lucknow.
- Medical Liability. Healthcare providers are subject to inherent risks of medical malpractice claims and litigation, which can result in significant financial and reputational damage.
Start your research today
Unlock AI insights, financials, peers and live data on Global Health Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,683 Cr
TTM · consolidated
NET PROFIT
₹552 Cr
TTM · consolidated
EPS
₹20.70
TTM · consolidated
RETURN ON EQUITY
15.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
17.2%
TTM · consolidated
P/E
71.0x
Q1 FY27 · consolidated
EV/EBITDA
37.6x
Q1 FY27 · consolidated
EBITDA MARGIN
23.0%
TTM · consolidated
NET PROFIT MARGIN
12.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q1 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Global Health Ltd.MEDANTA | ₹39,518 Cr | 71.00 | 37.60 | 21.3% | 23.0% | 15.0% | 17.2% | +3.4% |
Narayana Hrudayalaya Ltd.NH | ₹37,980 Cr | 46.25 | 22.61 | 57.8% | 20.5% | 20.0% | 15.4% | +1.1% |
Krishna Institute Of Medical Sciences LtdKIMS | ₹32,093 Cr | 149.82 | 40.63 | 30.9% | 20.6% | 8.9% | 9.2% | +3.5% |
Dr. Agarwal's Health Care LimitedAGARWALEYE | ₹16,296 Cr | 109.62 | 25.19 | — | 29.4% | 9.5% | 10.8% | +23.8% |
Rainbow Childrens Medicare LtdRAINBOW | ₹14,698 Cr | 51.48 | 23.97 | 18.3% | 33.6% | 18.6% | 18.7% | -4.8% |
Park Medi WorldPARKHOSPS | ₹12,364 Cr | — | — | — | 27.0% | — | — | — |
As of Q1 FY27
Financials
Global Health Ltd.
NSE: MEDANTA · Hospital
Snapshot
Unlock Global Health Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Global Health Limited is a multi-specialty tertiary care provider operating under the Medanta brand. The company delivers advanced medical treatments across various disciplines including cardiology, neurosciences, oncology, and organ transplantation through its network of hospitals in India.
Business Model
The company generates revenue by providing comprehensive healthcare services, including inpatient and outpatient care, diagnostic services, and complex surgical procedures. It operates a hub-and-spoke model with large-scale hospitals located in key Indian cities.
Growth Outlook
Growth is driven by the expansion of bed capacity across its existing hospital network and the increasing demand for high-end tertiary and quaternary care services in India. The company continues to focus on clinical excellence and the integration of advanced medical technologies.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including doctors and nursing staff, which may affect service quality and operational costs.
- Operational Concentration. The company's performance is heavily dependent on the operational success of its specific hospital locations in Gurugram, Indore, Ranchi, and Lucknow.
- Medical Liability. Healthcare providers are subject to inherent risks of medical malpractice claims and litigation, which can result in significant financial and reputational damage.
Start your research today
Unlock AI insights, financials, peers and live data on Global Health Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,683 Cr
TTM · consolidated
NET PROFIT
₹552 Cr
TTM · consolidated
EPS
₹20.70
TTM · consolidated
RETURN ON EQUITY
15.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
17.2%
TTM · consolidated
P/E
71.0x
Q1 FY27 · consolidated
EV/EBITDA
37.6x
Q1 FY27 · consolidated
EBITDA MARGIN
23.0%
TTM · consolidated
NET PROFIT MARGIN
12.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q1 FY27 · consolidated
Peers · Hospital
As of Q1 FY27